Skip to main content
. Author manuscript; available in PMC: 2016 Dec 15.
Published in final edited form as: Immunity. 2015 Dec 8;43(6):1112–1124. doi: 10.1016/j.immuni.2015.11.005

Figure 6. Qa-1 is preferentially expressed on ECTV-activated B cells.

Figure 6

(A) Splenocytes from naïve or ECTV-infected mice were assessed for Qa-1 expression. Qa-1 MFI of CD19+ versus CD19 splenocytes is shown on the left. Expression of Qa-1 on splenic B cells from naïve or ECTV-infected mice is shown on the right. (B) CD19+ popliteal lymph nodes B cells were assessed for H2-Kb-SIINFEKL and CD86 expression with specific antibodies 3 days after infection with EV/NP-S-GFP. (C) CD19+ splenic B cells were assessed H2-Kb-SIINFEKL and CD86 expression 7 days after infection with EV/NP-S-GFP or from uninfected naïve B cells. Data is representative of at least 3 independent experiments. Further supporting evidence can be found in Supplemental Figure 4.